Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: Post-hoc analyses from the GO-AFTER study

Josef S. Smolen, Jonathan Kay, Eric L. Matteson, Robert Landewé, Elizabeth C. Hsia, Stephen Xu, Yiying Zhou, Mittie K. Doyle

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: Post-hoc analyses from the GO-AFTER study'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds